Coherus NSCLC treatment toripalimab meets primary endpoint in late-stage trial
March 15 2022 - 8:13AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Apr 2024 to May 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From May 2023 to May 2024